Free UK shipping over £100Same-day dispatch before 2PM Mon–FriHigh-purity research productsCall or WhatsApp 07840 001329
Product documentation
Certificate of analysis
View COA

LABORATORY RESEARCH MATERIAL

CJC-1295 + Ipamorelin (No DAC) Blend

Price range: £39.99 through £94.99

Compound
CJC-1295 + Ipamorelin (No DAC) Blend
Amount per vial
10mg
Royal Mail Tracked delivery
UK delivery only
Delivery details
  • Royal Mail Tracked 48 (2–3 working days)£3.95
  • Royal Mail Tracked 24 (next working day)£5.95
  • Free UK shipping on orders over £100
DispatchOrders placed before 2pm Monday–Friday are dispatched the same day.

For laboratory and research use only. Not for human consumption. You must be 18 or over to order.

Product documentation
Certificate of analysis
View COA

PRODUCT INFORMATION

Details & documentation

Description

CJC-1295 + Ipamorelin (No DAC) Blend 10 mg and 20 mg

Buy CJC-1295 + Ipamorelin (No DAC) blend 10 mg or 20 mg for laboratory research. Each vial contains CJC-1295 without DAC and ipamorelin, combined as lyophilized powder. The two peptides are combined in equal amounts by mass.

  • 10 mg blend: 5 mg CJC-1295 (No DAC) + 5 mg ipamorelin per vial
  • 20 mg blend: 10 mg CJC-1295 (No DAC) + 10 mg ipamorelin per vial

CJC-1295 without DAC, also called modified GRF (1–29), is a 29-amino-acid analogue of growth hormone-releasing hormone with four amino-acid substitutions and no albumin-binding group. Ipamorelin is a synthetic pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2, identified by CAS 170851-70-4.

Choose the size and composition

The 10 mg and 20 mg blends contain the same two components in different total labeled amounts. Both share the same labeled 1:1 mass ratio. Equal milligram amounts would not imply equal numbers of molecules in any case, because the two peptides differ greatly in size.

CJC-1295 with DAC is a different molecule, sold as a separate product. This blend does not contain the DAC form, and it does not contain GHRP-2, GHRP-6 or sermorelin.

What the component research establishes

Raun and colleagues characterized ipamorelin in rat pituitary cells, anaesthetized rats and conscious swine. Its growth hormone-releasing potency and efficacy were comparable to GHRP-6, and in swine it did not raise ACTH or cortisol significantly beyond the levels seen with GHRH, unlike GHRP-6 and GHRP-2. These findings concern ipamorelin alone under those conditions.

Most published CJC-1295 research, including the albumin-binding work, concerns the DAC form and does not describe this component. Neither body of work describes the performance of this combined product.

Review the blend’s COA and product files

The COA & Documentation page contains the available batch reports and product documentation. Check the lot and size, the identity assigned to each component, and whether the report measures each peptide’s content separately. A combined purity percentage does not by itself confirm either labeled amount.

The composition above describes labeled material, not a measured result for every lot. For handling and storage, consult records applicable to the complete mixture.

Additional information

Strength

10mg, 20mg

CAS No.

CJC-1295 (No DAC): 863288-34-0, Ipamorelin: 170851-70-4

Product Format

Vial, Pre-loaded Cartridge, Pre-loaded Disposable Pen

Purity

≥99%

Applications

Growth hormone secretagogue research, GHRH and ghrelin receptor signalling studies, pituitary physiology investigations.

Synthesis

Solid-phase synthesis

Format

Lyophilized powder

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for 24 months at -20°C in lyophilized form.

Appearance

White powder

Shipping Conditions

Shipped at room temperature. Upon receipt, store at -20°C

Regulatory/Compliance

Complies with research use only standards. Not for drug, household, or other uses.

Batch documentation

Every batch, on record.

The certificate of analysis for the selected strength, with the results it reports and earlier batches. Certificates are published only after they have been received and reviewed.

10mg, VialCertificate on file
Purity (HPLC)
99.96%
Lot
IPA/CJC10-005
Test date
16 Apr 2026
Laboratory
Freedom Diagnostics
Measured content
Ipamorelin 5.74mg + CJC-1295 5.72mg
View certificate (PDF)
Reported results
TestMethodResult
Identity (mass identification)HPLC-UV + MSIpamorelin / CJC-1295 confirmed
PurityHPLC (UV)99.96% average (vials 99.96 / 99.94 / 99.94%)
Net peptide contentGravimetricIpamorelin 5.74 mg, CJC-1295 5.72 mg (average per vial)
AppearanceVisualWhite lyophilized powder
Endotoxin (replicate 1)LAL, ≤0.05 EU/mLPass
Endotoxin (replicate 2)LAL, ≤0.05 EU/mLPass

Research-use notice

This product is supplied strictly for laboratory, analytical and research purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment or self-administration. Read our Research-Use Disclaimer.

YOU MAY ALSO LIKE

Related research products

Semaglutide

Price range: £34.99 through £74.99

Melanotan I

Price range: £22.99 through £62.99

Lipo-C

Price range: £24.99 through £64.99

Glutathione

Price range: £34.99 through £74.99

Pepto Pure Labs

PLEASE CONFIRM

Research Use Only

By entering this website, you confirm that you are 18 years of age or older and understand that products supplied by Pepto Pure Labs are intended strictly for laboratory, analytical and research purposes only.

Products are not intended for human consumption, diagnosis, treatment or self-administration.